MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 160 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $31,443,000 | +127.0% | 599,151 | +43.9% | 0.03% | +158.3% |
Q2 2020 | $13,849,000 | +792.9% | 416,251 | +630.1% | 0.01% | +500.0% |
Q1 2020 | $1,551,000 | -89.7% | 57,014 | -92.5% | 0.00% | -83.3% |
Q4 2019 | $15,090,000 | -10.3% | 764,848 | -41.1% | 0.01% | -14.3% |
Q3 2019 | $16,815,000 | -16.5% | 1,297,486 | -19.8% | 0.01% | -22.2% |
Q2 2019 | $20,135,000 | -19.0% | 1,617,290 | -5.5% | 0.02% | -21.7% |
Q1 2019 | $24,862,000 | +51.8% | 1,711,090 | +15.3% | 0.02% | +27.8% |
Q4 2018 | $16,379,000 | -51.5% | 1,483,590 | +15.6% | 0.02% | -48.6% |
Q3 2018 | $33,748,000 | -37.5% | 1,283,200 | -54.2% | 0.04% | +20.7% |
Q2 2018 | $54,025,000 | +109.1% | 2,801,900 | +96.8% | 0.03% | +3.6% |
Q1 2018 | $25,835,000 | +17.0% | 1,423,400 | -10.1% | 0.03% | +16.7% |
Q4 2017 | $22,083,000 | -17.6% | 1,583,000 | +9.3% | 0.02% | -25.0% |
Q3 2017 | $26,797,000 | +98.8% | 1,448,500 | +81.7% | 0.03% | +88.2% |
Q2 2017 | $13,476,000 | +262.6% | 797,400 | +186.4% | 0.02% | +240.0% |
Q1 2017 | $3,717,000 | -37.8% | 278,400 | -29.9% | 0.01% | -44.4% |
Q4 2016 | $5,976,000 | +74.6% | 397,100 | +35.6% | 0.01% | +50.0% |
Q3 2016 | $3,423,000 | -13.1% | 292,800 | -19.7% | 0.01% | -14.3% |
Q2 2016 | $3,938,000 | -58.6% | 364,670 | -64.6% | 0.01% | -61.1% |
Q1 2016 | $9,508,000 | +16.4% | 1,029,051 | +86.9% | 0.02% | 0.0% |
Q4 2015 | $8,171,000 | +13.6% | 550,586 | +25.6% | 0.02% | +5.9% |
Q3 2015 | $7,194,000 | -32.4% | 438,366 | -6.1% | 0.02% | -29.2% |
Q2 2015 | $10,649,000 | +198.8% | 466,851 | +99.1% | 0.02% | +200.0% |
Q1 2015 | $3,564,000 | +28.5% | 234,451 | +1.8% | 0.01% | +14.3% |
Q4 2014 | $2,773,000 | -33.2% | 230,351 | -37.1% | 0.01% | -36.4% |
Q3 2014 | $4,154,000 | -36.3% | 366,351 | -32.2% | 0.01% | -26.7% |
Q2 2014 | $6,526,000 | +31.8% | 540,251 | +27.1% | 0.02% | +25.0% |
Q1 2014 | $4,953,000 | +450.3% | 425,134 | +611.5% | 0.01% | +500.0% |
Q2 2013 | $900,000 | – | 59,751 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 3,500,000 | $45,360,000 | 2.38% |
Palo Alto Investors LP | 1,757,122 | $22,772,000 | 1.52% |
Greencape Capital Pty Ltd | 270,280 | $3,503,000 | 1.24% |
GREAT POINT PARTNERS LLC | 1,000,000 | $12,960,000 | 1.19% |
Ghost Tree Capital, LLC | 350,000 | $4,536,000 | 1.16% |
Perceptive Advisors | 2,905,000 | $37,649,000 | 1.01% |
Eventide Asset Management | 1,236,000 | $16,019,000 | 0.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 80,000 | $1,036,000 | 0.48% |
PEREGRINE CAPITAL MANAGEMENT LLC | 832,627 | $10,791,000 | 0.29% |
Rock Springs Capital Management LP | 400,000 | $5,184,000 | 0.21% |